The Real Bottleneck in Healthcare Innovation
Why investors are asking harder questions about commercialization, adoption, and the realities of the healthcare system.
This week I attended the Bio Utah’s flagship Entrepreneur & Investor Life Sciences Summit here in Salt Lake City, Utah. The event gathers a familiar mix of people working at the intersection of science and business: research scientists presenting new technologies, early-stage founders hoping to turn those technologies into companies, and investors trying to determine which ideas might eventually become viable healthcare businesses.
The scientific innovation on display is remarkable. Across diagnostics, surgical technologies, imaging platforms, and digital health tools, there is no shortage of breakthroughs moving through research pipelines and startup labs. In fact, the scale of innovation in the life sciences sector is one of the reasons regions like Utah have become increasingly important hubs for healthcare entrepreneurship. According to BioUtah, the state’s life sciences ecosystem now includes more than 1,600 companies and supports roughly 180,000 jobs, contributing over $22 billion annually to the economy.
Kelvyn Cullimore, president and CEO of BioUtah, has pointed to the collaboration between universities, startups, and investors as a key driver of that growth, describing the emerging companies in the region as evidence of the “depth of innovation” developing across the research ecosystem.
In other words, innovation is not a scarce resource.
What becomes more interesting after spending time in rooms like this summit is the pattern that emerges in the conversations between founders and investors. During one portion of the event, several early-stage companies presented their technologies in a series of Shark Tank–style pitches. Each founder walked through the science behind their product, the size of the market opportunity, and the early traction they had achieved. The technologies themselves ranged widely—from fertility diagnostics and imaging agents to surgical devices and cardiac monitoring tools.
But once the presentations ended and the investors began asking questions, the conversation's focus shifted noticeably.
The questions were rarely about the underlying science. Instead, investors asked about commercialization strategy, regulatory pathways, reimbursement models, and adoption inside healthcare systems.
One investor asked a fertility diagnostics startup whether there was “broad awareness” of the product outside the small number of clinics already using it. Another investor pressed a surgical device founder on distribution strategy: would the company sell directly to hospitals, or rely on distributors to reach operating rooms? A cardiac screening company was asked how it planned to commercialize the product once regulatory approval was achieved, and whether it intended to build its own sales infrastructure or partner with existing healthcare providers.
The pattern repeated across the presentations. Investors wanted to understand regulatory timelines, reimbursement economics, and how the product would actually integrate into the clinical workflow of physicians and hospitals. In one exchange, a founder describing a new medical device was asked how hospitals would justify the cost of adopting it. The investor’s question was straightforward: could the company demonstrate measurable cost savings or improved outcomes that would motivate adoption?
What stood out about these conversations was not the skepticism of the investors. It was the consistency of their focus. Across very different technologies and markets, investors were asking essentially the same set of questions. They were trying to determine whether the company understood the system it would have to navigate.
Healthcare innovation has always been different from most other forms of entrepreneurship. A consumer technology startup can launch a product and quickly test whether users adopt it. Healthcare companies operate inside a far more complex environment. Regulatory agencies determine whether a product can be used. Payers determine whether it will be reimbursed. Hospital procurement systems determine whether physicians can access it. Clinical evidence determines whether doctors trust it.
The result is that innovation in healthcare must satisfy several different systems simultaneously before it reaches patients.
Large healthcare companies recognize this dynamic as well. Medtronic CEO Geoff Martha has argued that developing breakthrough medical technologies is only part of the challenge facing the industry. Ensuring those innovations can be delivered effectively and broadly within healthcare systems is equally critical to improving patient outcomes.
That reality also helps explain the growing focus on value-based care across the healthcare sector. Increasingly, reimbursement models are shifting away from simply paying for procedures and toward paying for measurable patient outcomes. The implication is that new technologies must demonstrate not only clinical effectiveness, but economic value within the broader healthcare system.
Seen through that lens, the questions investors asked during the pitch sessions begin to make more sense. They were not dismissing the scientific breakthroughs presented by the founders. They were trying to understand whether those breakthroughs could survive the structural realities of healthcare delivery.
In many ways, this points to a broader sequencing challenge that healthcare startups often face. The narrative of entrepreneurship tends to begin with the invention—the moment when a breakthrough technology or insight emerges. But in healthcare, the success of that breakthrough often depends on decisions that sit outside the laboratory. Questions about reimbursement strategy, clinical evidence generation, regulatory pathways, and provider adoption can determine whether innovation becomes widely used or quietly disappears.
None of this diminishes the importance of scientific discovery. Breakthrough technologies remain the foundation of progress in medicine. But the conversations at the summit offered a useful reminder that the path from innovation to patient impact rarely follows a straight line.
Healthcare is ultimately a system industry. Breakthrough ideas may begin the journey, but the system's structure determines whether those ideas reach the patients they are intended to help.
I know this was a little different from our typical Path newsletter, but I hope you found it interesting just the same.
As always, thanks for reading,
—Ryan
If you’re ready for life to feel more intentional, more aligned, and more within your control, this guide gives you the structure to make that shift real. Your next version starts with a single decision. Get the field guide
The Path is sponsored by: Taelor Style
A better way to dress for men on the go
Taelor is a subscription menswear service built for professionals and men on the go. Using AI and real stylists, Taelor curates outfits that fit your lifestyle—no shopping, no laundry, no decision fatigue. If you want to look sharp without spending mental energy on it, use code PATH at checkout for 25% off your first order.
Path Picks
Cool stuff to help you forge your path to greatness.
Note: The Path Weekly is reader-supported. As such, I may be using affiliate links below. If you want to support the newsletter at no additional cost to you, please consider using the links below. If you’d rather not, most items below are widely available anywhere you want to shop. Thanks! –R
Reading list
If you're looking to go deeper on the themes from this week's newsletter, here are a few books that pair well with the conversation and offer a broader perspective:
The Innovator’s Prescription — Clayton Christensen
Christensen’s classic applies the theory of disruptive innovation to healthcare. The book argues that many of the inefficiencies in healthcare come from the way the system is structured—and that real breakthroughs often come from innovations that simplify care and move it to lower-cost settings. For anyone trying to understand why healthcare startups face such complicated adoption challenges, this book is still one of the clearest explanations.
The Patient Will See You Now — Eric Topol
Topol explores how digital technologies, AI, and consumer access to medical data are reshaping healthcare delivery. While some of the predictions are ambitious, the book offers a thoughtful look at how the traditional healthcare system may evolve—and why innovation in medicine often collides with institutional inertia.
Not a healthcare book specifically, but extremely relevant for science-driven startups. Bahcall examines how breakthrough ideas often struggle to survive inside organizations and systems that are built for stability rather than experimentation. His concept of “loonshots”—wild ideas that eventually transform industries—offers a useful framework for understanding the tension between scientific discovery and commercial reality.
Redesigning Healthcare — Michael Porter & Elizabeth Teisberg
One of the foundational books behind the modern push toward value-based healthcare. Porter and Teisberg argue that healthcare systems should compete on patient outcomes rather than the volume of services delivered. That shift toward outcome-based care is shaping how investors, providers, and payers evaluate new healthcare technologies today.
More to explore
BioUtah — Utah’s Life Sciences Industry Organization
CMS Innovation Center — Federal initiatives around value-based healthcare
https://innovation.cms.gov
Would you like a personal introduction to any of the incredible leaders featured in The Path Weekly to explore business or other collaborative opportunities?
Contact me here to learn more about my B2B matchmaking service.
Want to put your brand in front of 13,000+ business and technology leaders each week? Contact me to learn more about sponsorship opportunities.
Work with me
RŌG Health - A commercial readiness and strategy firm for medtech companies, helping CEOs identify what’s blocking growth and make clear, de-risked decisions around commercialization, partnerships, and fundraising.
https://roghealth.com
Ryan Roghaar - Artist/Creative Director/Author
https://ryanroghaar.com
Eggs! The Podcast - https://www.eggscast.com
Get featured
Do you want to be featured in a future edition of The Path Weekly?
Contact me to learn more.